The genetics and screening of familial hypercholesterolaemia. Issue 1 (December 2016)

• Record Type: Journal Article
• Authors: Henderson, Raymond; O'Kane, Maurice; McGilligan, Victoria; Watterson, Steven
• Is Part Of: Journal of biomedical science. Volume 23:Issue 1(2016)
• Page Start: 1
• Page End: 12
• Publication Date: 2016-12
• Subjects: Familial hypercholesterolaemia -- FH -- cascade screening -- screening -- cholesterol -- universal screening -- atherosclerosis -- CVD -- CHD; Medical sciences -- Periodicals; 610.28
• DOI: 10.1186/s12929-016-0256-1
• Languages: English
• ISSNs: 1021-7770

Abstract

Abstract Familial Hypercholesterolaemia is an autosomal, dominant genetic disorder that leads to elevated blood cholesterol and a dramatically increased risk of atherosclerosis. It is perceived as a rare condition. However it affects 1 in 250 of the population globally, making it an important public health concern. In communities with founder effects, higher disease prevalences are observed. We discuss the genetic basis of familial hypercholesterolaemia, examining the distribution of variants known to be associated with the condition across the exons of the genesLDLR, ApoB, PCSK9 andLDLRAP1 . We also discuss screening programmes for familial hypercholesterolaemia and their cost-effectiveness. Diagnosis typically occurs using one of the Dutch Lipid Clinic Network (DCLN), Simon Broome Register (SBR) or Make Early Diagnosis to Prevent Early Death (MEDPED) criteria, each of which requires a different set of patient data. New cases can be identified by screening the family members of an index case that has been identified as a result of referral to a lipid clinic in a process called cascade screening. Alternatively, universal screening may be used whereby a population is systematically screened. It is currently significantly more cost effective to identify familial hypercholesterolaemia cases through cascade screening than universal screening. However, the cost of sequencing patient DNA has fallen dramatically in recent years and if the rate of progress continues, this may change.